Use of carbazole compounds for the treatment of congestive heart failure
USRE40707E1 · kind E1 · reissue
3Cited by
6References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 1996 |
| Grant date | May 5, 2009 |
| Priority date | — |
| Expiry date | Feb 7, 2016 |
Classification
- Technology area (CPC —)General
Abstract
A method of treatment using carvedilol is disclosed, wherein the carvedilol decreases the risk of mortality caused by congestive heart failure in patients. The patients are titrated with low amounts of carvedilol, with the initial titration dosage being only 10 to 30% of the daily maintenance dose.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.